Medicare drug price negotiations could save patients up to $700 per year, study finds

The study found that Americans enrolled in standalone Medicare Part D plans are projected to save an average of $685 per year, and people with Medicare Advantage plans could save about $470.

Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications

While diltiazem remains an effective option for heart rate control in selected patients, bleeding risk posed by anticoagulants should be considered.

Study shows sharp increase in appendix cancer for Generation X and millennials 

The findings reveal the need for increased awareness about appendiceal cancer from both clinicians and the public.

Study finds genetic screening of adults would be cost-effective

A Vanderbilt analysis of population genetic testing concludes with a recommendation to U.S. health policymakers to adopt routine testing of adults ages 40 and under for three genetic conditions posing high risk of life-threatening illness.

Diabetes drugs associated with fewer adverse cardiac events in older veterans: study

Vanderbilt research finds that GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease.

Study shows genotype leads to discontinued, decreased medication